0001769072-23-000004.txt : 20230207 0001769072-23-000004.hdr.sgml : 20230207 20230207164126 ACCESSION NUMBER: 0001769072-23-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 EFFECTIVENESS DATE: 20230207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hanimune Therapeutics Inc CENTRAL INDEX KEY: 0001769072 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-472872 FILM NUMBER: 23595637 BUSINESS ADDRESS: STREET 1: 1711 NORTH HOWARD STREET CITY: PHILADELPHIA STATE: PA ZIP: 19122 BUSINESS PHONE: 732-713-4976 MAIL ADDRESS: STREET 1: PO BOX 29307 CITY: PHILADELPHIA STATE: PA ZIP: 19125 FORMER COMPANY: FORMER CONFORMED NAME: Lil Mixins, LLC DATE OF NAME CHANGE: 20190226 D 1 primary_doc.xml X0708 D LIVE 0001769072 Hanimune Therapeutics Inc 1711 NORTH HOWARD STREET PHILADELPHIA PA PENNSYLVANIA 19122 484-816-6467 DELAWARE Lil Mixins, LLC Corporation true Meenal Lele 1711 North Howard Street Philadelphia PA PENNSYLVANIA 19125 Executive Officer Director Chief Executive Officer Hany Michail c/o BioAdvance 170 N Radnor Chester Rd Wayne PA PENNSYLVANIA 19087 Director Agriculture Decline to Disclose 06b false 2023-01-24 false true false 0 5064275 3304288 1759987 $1,772,907.95 of the Total Offering Amount and Total Amount Sold includes principal and interest due on certain instruments convertible or exercisable into equity of the Issuer. false 33 0 0 0 The Issuer will use the proceeds for working capital and other general corporate purposes. false Hanimune Therapeutics Inc Meenal Lele Meenal Lele Chief Executive Officer 2023-02-07